Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis.
Fingolimod phosphate promotes the neuroprotective effects of microglia.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Motor skill learning requires active central myelination.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Copolymer 1 inhibits manifestations of graft rejection.
The antioxidant idebenone fails to prevent or attenuate chronic experimental autoimmune encephalomyelitis in the mouse.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Identification of the LDL Receptor-Related Protein-1 Interactome in Central Nervous System myelin suggests a role in the clearance of necrotic cell debris.
Laquinimod Phase IIa Study in Active Crohn's Disease
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
First-line natalizumab in multiple sclerosis: rationale, patient selection, benefits and risks.
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Shorter washout reduces MS relapse switching off natalizumab

Pages